We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Rexford Industrial Realty
REXR
$8.66B
| $1.66M | ﹤0.01% |
31,796
-2,609
| -8% | -$142K |
|
1002
Under Armour
UAA
$2.15B
| $1.66M | ﹤0.01% |
229,841
-49,288
| -18% | -$396K |
|
|
PXD
1003
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.65M | ﹤0.01% |
7,980
-3,265
| -29% | -$687K |
|
1004
Dollar Tree
DLTR
$21.1B
| $1.65M | ﹤0.01% |
11,520
-513,499
| -98% | -$75.5M |
|
1005
Republic Services
RSG
$67.3B
| $1.65M | ﹤0.01% |
10,783
+284
| +3% | +$40.6K |
|
1006
Supernus Pharmaceuticals
SUPN
$2.41B
| $1.65M | ﹤0.01% |
54,890
-27,231
| -33% | -$953K |
|
1007
Ryder
R
$9.13B
| $1.65M | ﹤0.01% |
19,458
+1,134
| +6% | +$93.4K |
|
1008
GoPro
GPRO
$262M
| $1.65M | ﹤0.01% |
398,206
+327,462
| +463% | +$1.4M |
|
1009
Novavax
NVAX
$1.54B
| $1.64M | ﹤0.01% |
221,313
+141,640
| +178% | +$1.11M |
|
1010
Atlanta Braves Holdings Series B
BATRK
$3.25B
| $1.63M | ﹤0.01% |
41,267
-12,076
| -23% | -$453K |
|
1011
Invesco Mortgage Capital
IVR
$695M
| $1.63M | ﹤0.01% |
141,989
+575
| +0.4% | +$6.15K |
|
1012
EastGroup Properties
EGP
$10.6B
| $1.62M | ﹤0.01% |
9,348
+651
| +7% | +$109K |
|
1013
Jacobs Solutions
J
$16.8B
| $1.62M | ﹤0.01% |
16,473
| – | – |
|
1014
Fulgent Genetics
FLGT
$595M
| $1.61M | ﹤0.01% |
43,590
-28,712
| -40% | -$1M |
|
|
SVC
1015
Service Properties Trust
SVC
$857M
| $1.61M | ﹤0.01% |
37,103
-677
| -2% | -$29.7K |
|
1016
Golar LNG
GLNG
$5.14B
| $1.61M | ﹤0.01% |
79,711
+63,943
| +406% | +$1.37M |
|
|
RETA
1017
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.61M | ﹤0.01% |
15,756
-941
| -6% | -$89K |
|
1018
Healthcare Realty
HR
$6.34B
| $1.61M | ﹤0.01% |
85,179
-2,110
| -2% | -$40.7K |
|
|
PDCE
1019
DELISTED
PDC Energy, Inc.
PDCE
| $1.6M | ﹤0.01% |
22,497
-1,384
| -6% | -$93.5K |
|
1020
Globe Life
GL
$13.3B
| $1.59M | ﹤0.01% |
14,534
-534
| -4% | -$57.4K |
|
1021
East-West Bancorp
EWBC
$17.3B
| $1.59M | ﹤0.01% |
30,166
-5,089
| -14% | -$258K |
|
1022
CubeSmart
CUBE
$8.94B
| $1.58M | ﹤0.01% |
35,415
-1,254
| -3% | -$56.9K |
|
1023
Turning Point Brands
TPB
$1.41B
| $1.58M | ﹤0.01% |
65,752
-23,762
| -27% | -$534K |
|
1024
Lincoln Electric
LECO
$13.9B
| $1.57M | ﹤0.01% |
7,929
-249
| -3% | -$43.4K |
|
1025
First American
FAF
$7.26B
| $1.57M | ﹤0.01% |
27,619
+3,893
| +16% | +$220K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.